Enochian Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.12.24	RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program (GlobeNewswire)
20.12.24	Renovaro Regains Compliance with NASDAQ Listing Requirement (GlobeNewswire)
20.12.24	Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection (GlobeNewswire)
04.11.24	Renovaro Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire)
17.10.24	RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing (GlobeNewswire)
16.10.24	Renovaro Announces Strategic Restructuring and Leadership Transition (GlobeNewswire)
19.09.24	PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics (GlobeNewswire)
17.09.24	Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection (GlobeNewswire)
13.09.24	RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress (GlobeNewswire)
11.09.24	Renovaro To Seek Funds From Strategic Investors To Acquire Up To 20% Of RenovaroCube (RTTNews)
11.09.24	RenovaroCube Announces Strategic Offering of Up to 20% Ownership (GlobeNewswire)
14.06.24	Renovaro, Inc. Announces $10 million in Equity Committed (GlobeNewswire)
24.05.24	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy (GlobeNewswire)
30.04.24	Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics (GlobeNewswire)
24.04.24	RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
18.04.24	Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Missio (GlobeNewswire)
15.02.24	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire)
14.02.24	Statement of Renovaro Inc (GlobeNewswire)
13.02.24	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire)
13.02.24	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
25.01.24	Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire)
16.01.24	Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
11.10.23	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors (GlobeNewswire)
10.10.23	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors (GlobeNewswire)
02.10.23	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine (GlobeNewswire)
29.09.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC (PR Newswire)
29.09.23	Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine (GlobeNewswire)
05.09.23	Pre-market Movers: HSDT, UPTD, ADTX, RENB, MLGO… (RTTNews)
30.08.23	Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort (GlobeNewswire)
21.08.23	Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer (GlobeNewswire)
09.08.23	AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer (GlobeNewswire)
23.06.23	Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting (GlobeNewswire)
08.06.23	Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review (GlobeNewswire)
03.04.23	Enochian BioSciences’ CEO Letter to Shareholders (GlobeNewswire)
29.03.23	Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher (GlobeNewswire)
13.03.23	Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements (GlobeNewswire)
23.02.23	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 (GlobeNewswire)
24.10.22	Enochian BioSciences Forges Ahead With Focused Approach, Promising Future (GlobeNewswire)
21.10.22	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
17.10.22	Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform (GlobeNewswire)
18.09.22	ENOB FINAL DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB (PR Newswire)
15.09.22	Pre-market Movers: ATXG, FWBI, IDYA, ENOB, LUCY… (RTTNews)
14.09.22	ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB (PR Newswire)
06.09.22	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB (PR Newswire)
29.08.22	ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB (PR Newswire)
23.08.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB (PR Newswire)
16.08.22	ENOB LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Act... (PR Newswire)
06.08.22	ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB (PR Newswire)
30.07.22	ROSEN,TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ENOB (PR Newswire)
25.07.22	Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	74.90	0.64 %	K V
Kuehne+Nagel Int	208.40	0.43 %	K V
Swiss Life Hldg	700.20	0.40 %	K V
Roche Hldg G	254.40	0.32 %	K V
Swisscom	504.50	0.30 %	K V
Swiss Re	131.30	-0.27 %	K V
Givaudan	3’970.00	-0.30 %	K V
Geberit	515.20	-0.35 %	K V
Lonza Grp	535.60	-0.45 %	K V
ABB	49.06	-0.97 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Enochian Biosciences Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten